Compare ACA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACA | INDV |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | 2018 | 2014 |
| Metric | ACA | INDV |
|---|---|---|
| Price | $119.99 | $37.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | 247.7K | ★ 2.0M |
| Earning Date | 04-30-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | 121.99 | ★ 8100.00 |
| EPS | ★ 0.77 | 0.69 |
| Revenue | ★ $2,883,400,000.00 | $1,239,000,000.00 |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | $152.71 | ★ $53.49 |
| Revenue Growth | ★ 12.20 | 4.29 |
| 52 Week Low | $81.91 | $11.08 |
| 52 Week High | $135.58 | $41.00 |
| Indicator | ACA | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 58.90 |
| Support Level | $92.54 | $29.71 |
| Resistance Level | $132.24 | $37.83 |
| Average True Range (ATR) | 4.97 | 1.36 |
| MACD | -1.46 | -0.32 |
| Stochastic Oscillator | 20.97 | 37.98 |
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).